For qualified investors in Chile

Amid volatility, healthcare’s appeal grows

WEBCAST: Amid volatility, healthcare's appeal grows

Andy Acker, CFA

Andy Acker, CFA

Global Life Sciences | Portfolio Manager


2 Nov 2022
21 minute watch

Amid an environment of higher-than-expected inflation, rate hikes and a slowing global economy, health care’s defensive nature may offer attractive characteristics. In our view, depressed valuations and accelerating innovation make biotech particularly appealing, while other areas of healthcare could continue to shine near term.

Watch here as Portfolio Manager Andy Acker explains why the sector could offer both defence against market volatility and opportunities for long-term gains.

These are the views of the author at the time of publication and may differ from the views of other individuals/teams at Janus Henderson Investors. Any securities, funds, sectors and indices mentioned within this article do not constitute or form part of any offer or solicitation to buy or sell them.

 

Past performance does not predict future returns. The value of an investment and the income from it can fall as well as rise and you may not get back the amount originally invested.

 

The information in this article does not qualify as an investment recommendation.

 

Marketing Communication.

 

Glossary

 

 

 

Andy Acker, CFA

Andy Acker, CFA

Global Life Sciences | Portfolio Manager


2 Nov 2022
21 minute watch